Mutations of METTL3 predict response to neoadjuvant chemotherapy in muscle-invasive bladder cancer. Yang Z, Shen Z, Jin D, Zhang N, et al. J Clin Transl Res 2021;7:386-413.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yang Z, Shen Z, Jin D, Zhang N, et al. Mutations of METTL3 predict response to neoadjuvant chemotherapy in muscle-invasive bladder cancer. J Clin Transl Res 2021;7:386-413.
PMID: 34239995